Table 1.
Characteristics of participants.
| All participants | Participants without past COVID-19 infection | Participants with past COVID-19 infection | |||||||
| Variable | HIV+ (n = 256) | HIV− (n = 256) | P | HIV+ (n = 211) | HIV− (n = 200) | P | HIV+ (n = 45) | HIV− (n = 56) | P |
| COVID infection prior to 3 months post dose 2 (±1 month) sample [n (%)] | 45 (17.6) | 56 (21.9) | – | 0 (0%) | 0 (0%) | – | 45 (100.0) | 56 (100.0) | – |
| Time since COVID infection, days prior to sample collection | 0.244 | ||||||||
| Median (IQR) | – | – | – | – | 263 (126, 338) | 306 (168, 472) | |||
| Range | – | – | – | – | (25–685) | (17–583) | |||
| Missing | – | – | – | – | 19 | 2 | |||
| Age | <0.001 | <0.001 | 0.133 | ||||||
| Median (IQR) | 54.2 (43.4, 62.8) | 45.5 (35.0, 57.0) | 54.6 (44.0, 63.6) | 45.0 (36.0, 56.0) | 53.3 (42.8, 60.2) | 49.0 (33.0, 58.5) | |||
| Range | (19.7–83.5) | (22.0–79.0) | (19.7–83.5) | (22.0–79.0) | (25.9–73.9) | (23.0–75.0) | |||
| <0.001 | <0.001 | 0.342 | |||||||
| Number missing | 1 | 0 | 1 | 0 | 0 | 0 | |||
| <35 | 30 (11.8) | 59 (23.0) | 24 (11.4) | 42 (21.0) | 6 (13.3) | 17 (30.4) | |||
| 35–44 | 40 (15.7) | 62 (24.2) | 33 (15.7) | 55 (27.5) | 7 (15.6) | 7 (12.5) | |||
| 45–54 | 64 (25.1) | 56 (21.9) | 50 (23.8) | 44 (22.0) | 14 (31.1) | 12 (21.4) | |||
| 55–64 | 73 (28.6) | 52 (20.3) | 60 (28.6) | 39 (19.5) | 13 (28.9) | 13 (23.2) | |||
| 65–74 | 38 (14.9) | 24 (9.4) | 33 (15.7) | 18 (9.0) | 5 (11.1) | 6 (10.7) | |||
| ≥75 | 10 (3.9) | 3 (1.2) | 10 (4.8) | 2 (1.0) | 0 (0.0) | 1 (1.8) | |||
| Sex | <0.001 | <0.001 | 0.04 | ||||||
| Male | 183 (71.5) | 89 (34.8) | 153 (72.5) | 64 (32.0) | 30 (66.7) | 25 (44.6) | |||
| Female | 72 (28.1) | 167 (65.2) | 57 (27.0) | 136 (68.0) | 15 (33.3) | 31 (55.4) | |||
| Prefer to self describe | 1 (0.4) | 0 (0) | 1 (0.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |||
| Self-declared race or ethnicitya | <0.001 | <0.001 | <0.001 | ||||||
| White | 138 (54.5) | 228 (89.1) | 123 (58.9) | 179 (89.5) | 15 (34.1) | 49 (87.5) | |||
| Black | 59 (23.3) | 0 (0) | 41 (19.6) | 0 (0.0) | 18 (40.9) | 0 (0.0) | |||
| Other | 56 (22.1) | 28 (10.9) | 45 (21.5) | 21 (10.5) | 11 (25.0) | 7 (12.5) | |||
| Unknown | 3 | 0 | 2 | 0 | 1 | 0 | |||
| Subpopulation | |||||||||
| Age >55 years | 121/255 (47.5) | 79/256 (30.9) | <0.001 | 103/210 (49.0) | 59/200 (29.5) | <0.001 | 18/45 (40.0) | 20/56 (35.7) | 0.659 |
| Multimorbidity (≥2 comorbidities) | 90/252 (35.7) | 56/253 (22.1) | <0.001 | 74/208 (35.6) | 44/199 (22.1) | 0.003 | 16/44 (36.4) | 12/54 (22.2) | 0.123 |
a
Multiple could be selected.